Based on this, metformin, the most widely used anti-diabetic drug which had been reported to activate AMPK signal pathway, [13] was used in the second in vivo study to evaluate its pharmacological effects in AAA progression. The gene discussed is PRKAA2; the disease is triple-A syndrome.